306 related articles for article (PubMed ID: 25968487)
1. The effect of intravesical chemotherapy in the prevention of intravesical recurrence after nephroureterectomy for upper tract urothelial carcinoma: a meta-analysis.
Yuan H; Mao X; Bai Y; Li H; Liu L; Pu C; Li J; Tang Y; Wei Q; Han P
J Chemother; 2015 Aug; 27(4):195-200. PubMed ID: 25968487
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic intravesical chemotherapy decreases bladder tumor recurrence after nephroureterectomy for primary upper tract urothelial carcinoma: A systematic review and meta-analysis.
Wu P; Zhu G; Wei D; Liu S; Walsh K; Li D; Harron U; Wang X; Ma H; Wan B; Sun L; Yang Z; Wang J
J BUON; 2015; 20(5):1229-38. PubMed ID: 26537069
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic intravesical chemotherapy to prevent bladder tumors after nephroureterectomy for primary upper urinary tract urothelial carcinomas: a systematic review and meta-analysis.
Fang D; Li XS; Xiong GY; Yao L; He ZS; Zhou LQ
Urol Int; 2013; 91(3):291-6. PubMed ID: 23948770
[TBL] [Abstract][Full Text] [Related]
4. A Comparison of Different Prophylactic Intravesical Chemotherapy Regimens for Bladder Cancer Recurrence After Nephroureterectomy for Primary Upper Tract Urothelial Carcinomas: A Retrospective 2-center Study.
Huang Y; Cen J; Liu Z; Wei J; Chen Z; Feng Z; Lu J; Fang Y; Zhou F; Luo J; Mo C; Chen W
Technol Cancer Res Treat; 2019 Jan; 18():1533033819844483. PubMed ID: 30987527
[TBL] [Abstract][Full Text] [Related]
5. Single-dose intravesical chemotherapy after nephroureterectomy for upper tract urothelial carcinoma.
Hwang EC; Sathianathen NJ; Jung JH; Kim MH; Dahm P; Risk MC
Cochrane Database Syst Rev; 2019 May; 5(5):CD013160. PubMed ID: 31102534
[TBL] [Abstract][Full Text] [Related]
6. Intravesical seeding of upper urinary tract urothelial carcinoma cells during nephroureterectomy: an exploratory analysis from the THPMG trial.
Ito A; Shintaku I; Satoh M; Ioritani N; Tochigi T; Numata I; Namima T; Kambe K; Kyan A; Ueno S; Katoh S; Adachi H; Yamashita S; Yamaguchi T; Arai Y;
Jpn J Clin Oncol; 2013 Nov; 43(11):1139-44. PubMed ID: 24006504
[TBL] [Abstract][Full Text] [Related]
7. Prospective randomized phase II trial of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP Monotherapy Study Group Trial.
Ito A; Shintaku I; Satoh M; Ioritani N; Aizawa M; Tochigi T; Kawamura S; Aoki H; Numata I; Takeda A; Namiki S; Namima T; Ikeda Y; Kambe K; Kyan A; Ueno S; Orikasa K; Katoh S; Adachi H; Tokuyama S; Ishidoya S; Yamaguchi T; Arai Y
J Clin Oncol; 2013 Apr; 31(11):1422-7. PubMed ID: 23460707
[TBL] [Abstract][Full Text] [Related]
8. Muscle-invasive bladder cancer developing after nephroureterectomy for upper urinary tract urothelial carcinoma.
Kim KH; You D; Jeong IG; Hong JH; Ahn H; Kim CS
Urol Oncol; 2013 Nov; 31(8):1643-9. PubMed ID: 22591745
[TBL] [Abstract][Full Text] [Related]
9. Independent prognostic factors for initial intravesical recurrence after laparoscopic nephroureterectomy for upper urinary tract urothelial carcinoma.
Liu Y; Lu J; Hong K; Huang Y; Ma L
Urol Oncol; 2014 Feb; 32(2):146-52. PubMed ID: 23628312
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of early ureteral ligation on prevention of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma: a prospective single-arm multicenter clinical trial.
Yamashita S; Ito A; Mitsuzuka K; Ioritani N; Ishidoya S; Ikeda Y; Numahata K; Orikasa K; Tochigi T; Soma F; Namima T; Arai Y
Jpn J Clin Oncol; 2017 Sep; 47(9):870-875. PubMed ID: 28903527
[TBL] [Abstract][Full Text] [Related]
11. A Systematic Review and Meta-analysis of Clinicopathologic Factors Linked to Intravesical Recurrence After Radical Nephroureterectomy to Treat Upper Tract Urothelial Carcinoma.
Seisen T; Granger B; Colin P; Léon P; Utard G; Renard-Penna R; Compérat E; Mozer P; Cussenot O; Shariat SF; Rouprêt M
Eur Urol; 2015 Jun; 67(6):1122-1133. PubMed ID: 25488681
[TBL] [Abstract][Full Text] [Related]
12. [Nephroureterectomy for upper tract urothelial carcinoma : Effectiveness of single-dose intravesical chemotherapy].
Spek A
Urologe A; 2020 Apr; 59(4):480-483. PubMed ID: 32100070
[No Abstract] [Full Text] [Related]
13. Should patients with primary upper urinary tract cancer receive prophylactic intravesical chemotherapy after nephroureterectomy?
Wu WJ; Ke HL; Yang YH; Li CC; Chou YH; Huang CH
J Urol; 2010 Jan; 183(1):56-61. PubMed ID: 19913833
[TBL] [Abstract][Full Text] [Related]
14. Tumour multifocality and grade predict intravesical recurrence after nephroureterectomy in patients with upper urinary tract urothelial carcinoma without a history of bladder cancer.
Narukawa T; Hara T; Arai E; Komiyama M; Kawahara T; Kanai Y; Fujimoto H
Jpn J Clin Oncol; 2015 May; 45(5):488-93. PubMed ID: 25681388
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the safety of intraoperative instillation of intravesical chemotherapy at the time of nephroureterectomy.
Moriarty MA; Uhlman MA; Bing MT; O'Donnell MA; Brown JA; Tracy CR; Deorah S; Nepple KG; Gupta A
BMC Urol; 2015 May; 15():45. PubMed ID: 26018765
[TBL] [Abstract][Full Text] [Related]
16. [Effect of prophylactic intravesical instillation of pirarubicin to prevent recurrent bladder tumors following nephroureterectomy for upper urinary tract cancer].
Nagashima M; Araki A; Yanagisawa M; Komiya A; Takano T; Murakami T; Ikeda I
Hinyokika Kiyo; 2013 Apr; 59(4):213-6. PubMed ID: 23635455
[TBL] [Abstract][Full Text] [Related]
17. Epidermal Growth Factor Receptor and Ki-67 as Predictive Biomarkers Identify Patients Who Will Be More Sensitive to Intravesical Instillations for the Prevention of Bladder Cancer Recurrence after Radical Nephroureterectomy.
Long X; Zu X; Li Y; He W; Hu X; Tong S; Wang Z; Chen M; Qi L
PLoS One; 2016; 11(11):e0166884. PubMed ID: 27870887
[TBL] [Abstract][Full Text] [Related]
18. Assessment of Therapeutic Benefit and Option Strategy on Intravesical Instillation for Preventing Bladder Cancer Recurrence after Radical Nephroureterectomy in Patients with Upper Urinary Tract Urothelial Carcinoma.
Fan B; Teng Q; Sun M; Wang Y; Wang Y; Lin Z; Wang Y; Duan X; Zhang L; Chen T; Chen S; Tai Y; Zhang C; Song X; Liu Z
J Oncol; 2022; 2022():1755368. PubMed ID: 35677889
[TBL] [Abstract][Full Text] [Related]
19. Predictive factors for bladder recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma.
Cho DS; Kim SI; Ahn HS; Kim SJ
Urol Int; 2013; 91(2):153-9. PubMed ID: 23391941
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for bladder cancer recurrence after nephroureterectomy for upper tract urothelial tumors: results from the Canadian Upper Tract Collaboration.
Fradet V; Mauermann J; Kassouf W; Rendon R; Jacobsen N; Fairey A; Izawa J; Kapoor A; Black P; Tanguay S; Chin J; So A; Lattouf JB; Bell D; Saad F; Sheyegan B; Drachenberg D; Cagiannos I; Lacombe L
Urol Oncol; 2014 Aug; 32(6):839-45. PubMed ID: 24856978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]